Identification of a Lipokine, a Lipid Hormone Linking Adipose Tissue to Systemic Metabolism

Cell

Volumn 134, Issue 6, 2008, Pages 933-944

  Cao, Haiming ^a   Gerhold, Kristin ^a   Mayers, Jared R ^a   Wiest, Michelle M ^b   Watkins, Steven M ^b   Hotamisligil, Gökhan S ^a  

^a HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^b Lipomics Technologies   (United States)

Author keywords

CELLBIO; HUMDISEASE

Indexed keywords

BLOCKING AGENT; CHAPERONE; CHAPERONE PROTEIN AP2; CHAPERONE PROTEIN AP2 INHIBITOR; CHAPERONE PROTEIN MAL1; FATTY ACID; HORMONE; LIPOKINE; PALMITOLEIC ACID; UNCLASSIFIED DRUG;

ADIPOSE TISSUE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DISORDERS OF LIPID AND LIPOPROTEIN METABOLISM; ENDOCRINE FUNCTION; FATTY ACID METABOLISM; FATTY LIVER; HOMEOSTASIS; LIPID ANALYSIS; LIPID COMPOSITION; LIPID METABOLISM; LIPOGENESIS; METABOLIC REGULATION; MOUSE; NONHUMAN; OBESITY; PRIORITY JOURNAL;

MUS;

EID: 51549107903     PISSN: 00928674     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cell.2008.07.048     Document Type: Article

References (31)

1. Avramoglu R.K., Basciano H., and Adeli K. Lipid and lipoprotein dysregulation in insulin resistant states. Clin. Chim. Acta 368 (2006) 1-19
2. Bergman R.N., and Ader M. Free fatty acids and pathogenesis of type 2 diabetes mellitus. Trends Endocrinol. Metab. 11 (2000) 351-356
3. Cao H., Maeda K., Gorgun C.Z., Kim H.J., Park S.Y., Shulman G.I., Kim J.K., and Hotamisligil G.S. Regulation of metabolic responses by adipocyte/macrophage Fatty Acid-binding proteins in leptin-deficient mice. Diabetes 55 (2006) 1915-1922
4. Chu K., Miyazaki M., Man W.C., and Ntambi J.M. Stearoyl-coenzyme A desaturase 1 deficiency protects against hypertriglyceridemia and increases plasma high-density lipoprotein cholesterol induced by liver X receptor activation. Mol. Cell. Biol. 26 (2006) 6786-6798
5. Eckel R.H., Grundy S.M., and Zimmet P.Z. The metabolic syndrome. Lancet 365 (2005) 1415-1428
6. Field C.J., and Clandinin M.T. Modulation of adipose tissue fat composition by diet: A review. Nutr. Res. 4 (1984) 743-755
7. Folch J., Lees M., and Sloane Stanley G.H. A simple method for the isolation and purification of total lipides from animal tissues. J. Biol. Chem. 226 (1957) 497-509
8. Furuhashi M., and Hotamisligil G.S. Fatty acid-binding proteins: Role in metabolic diseases and potential as drug targets. Nat. Rev. Drug Discov. 7 (2008) 489-503
9. Furuhashi M., Tuncman G., Gorgun C.Z., Makowski L., Atsumi G., Vaillancourt E., Kono K., Babaev V.R., Fazio S., Linton M.F., et al. Treatment of diabetes and atherosclerosis by inhibiting fatty-acid-binding protein aP2. Nature 447 (2007) 959-965
10. Ginsberg H.N., Zhang Y.L., and Hernandez-Ono A. Metabolic syndrome: Focus on dyslipidemia. Obesity (Silver Spring) 14 Suppl 1 (2006) 41S-49S
11. Heinemann F.S., and Ozols J. Stearoyl-CoA desaturase, a short-lived protein of endoplasmic reticulum with multiple control mechanisms. Prostaglandins Leukot. Essent. Fatty Acids 68 (2003) 123-133
12. Hiraoka-Yamamoto J., Ikeda K., Negishi H., Mori M., Hirose A., Sawada S., Onobayashi Y., Kitamori K., Kitano S., Tashiro M., et al. Serum lipid effects of a monounsaturated (palmitoleic) Fatty Acid-rich diet based on macadamia nuts in healthy, young Japanese women. Clin. Exp. Pharmacol. Physiol. 31 Suppl 2 (2004) S37-S38
13. Hotamisligil G.S. Inflammation and metabolic disorders. Nature 444 (2006) 860-867
14. Hotamisligil G.S., Johnson R.S., Distel R.J., Ellis R., Papaioannou V.E., and Spiegelman B.M. Uncoupling of obesity from insulin resistance through a targeted mutation in aP2, the adipocyte fatty acid binding protein. Science 274 (1996) 1377-1379
15. Kim J.K., Fillmore J.J., Sunshine M.J., Albrecht B., Higashimori T., Kim D.W., Liu Z.X., Soos T.J., Cline G.W., O'Brien W.R., et al. PKC-theta knockout mice are protected from fat-induced insulin resistance. J. Clin. Invest. 114 (2004) 823-827
16. Kim J.Y., van de Wall E., Laplante M., Azzara A., Trujillo M.E., Hofmann S.M., Schraw T., Durand J.L., Li H., Li G., et al. Obesity-associated improvements in metabolic profile through expansion of adipose tissue. J. Clin. Invest. 117 (2007) 2621-2637
17. Kuriyama H., Liang G., Engelking L.J., Horton J.D., Goldstein J.L., and Brown M.S. Compensatory increase in fatty acid synthesis in adipose tissue of mice with conditional deficiency of SCAP in liver. Cell Metab. 1 (2005) 41-51
18. Maeda K., Cao H., Kono K., Gorgun C.Z., Furuhashi M., Uysal K.T., Cao Q., Atsumi G., Malone H., Krishnan B., et al. Adipocyte/macrophage fatty acid binding proteins control integrated metabolic responses in obesity and diabetes. Cell Metab. 1 (2005) 107-119
19. Moraes R.C., Blondet A., Birkenkamp-Demtroeder K., Tirard J., Orntoft T.F., Gertler A., Durand P., Naville D., and Begeot M. Study of the alteration of gene expression in adipose tissue of diet-induced obese mice by microarray and reverse transcription-polymerase chain reaction analyses. Endocrinology 144 (2003) 4773-4782
20. Nadler S.T., Stoehr J.P., Schueler K.L., Tanimoto G., Yandell B.S., and Attie A.D. The expression of adipogenic genes is decreased in obesity and diabetes mellitus. Proc. Natl. Acad. Sci. USA 97 (2000) 11371-11376
21. Newberry E.P., Xie Y., Kennedy S.M., Luo J., and Davidson N.O. Protection against Western diet-induced obesity and hepatic steatosis in liver fatty acid-binding protein knockout mice. Hepatology 44 (2006) 1191-1205
22. Ntambi J.M. Regulation of stearoyl-CoA desaturase by polyunsaturated fatty acids and cholesterol. J. Lipid Res. 40 (1999) 1549-1558
23. Ntambi J.M., and Miyazaki M. Regulation of stearoyl-CoA desaturases and role in metabolism. Prog. Lipid Res. 43 (2004) 91-104
24. Paillard F., Catheline D., Duff F.L., Bouriel M., Deugnier Y., Pouchard M., Daubert J.C., and Legrand P. Plasma palmitoleic acid, a product of stearoyl-coA desaturase activity, is an independent marker of triglyceridemia and abdominal adiposity. Nutr. Metab. Cardiovasc. Dis. 18 (2007) 436-440
25. Stein D.T., Stevenson B.E., Chester M.W., Basit M., Daniels M.B., Turley S.D., and McGarry J.D. The insulinotropic potency of fatty acids is influenced profoundly by their chain length and degree of saturation. J. Clin. Invest. 100 (1997) 398-403
26. Tuncman G., Erbay E., Hom X., De Vivo I., Campos H., Rimm E.B., and Hotamisligil G.S. A genetic variant at the fatty acid-binding protein aP2 locus reduces the risk for hypertriglyceridemia, type 2 diabetes, and cardiovascular disease. Proc. Natl. Acad. Sci. USA 103 (2006) 6970-6975
27. Waki H., Park K.W., Mitro N., Pei L., Damoiseaux R., Wilpitz D.C., Reue K., Saez E., and Tontonoz P. The small molecule harmine is an antidiabetic cell-type-specific regulator of PPARgamma expression. Cell Metab. 5 (2007) 357-370
28. Warensjo E., Riserus U., and Vessby B. Fatty acid composition of serum lipids predicts the development of the metabolic syndrome in men. Diabetologia 48 (2005) 1999-2005
29. Waters K.M., Miller C.W., and Ntambi J.M. Localization of a polyunsaturated fatty acid response region in stearoyl-CoA desaturase gene 1. Biochim. Biophys. Acta 1349 (1997) 33-42
30. Watkins S.M., Reifsnyder P.R., Pan H.J., German J.B., and Leiter E.H. Lipid metabolome-wide effects of the PPARgamma agonist rosiglitazone. J. Lipid Res. 43 (2002) 1809-1817
31. Yu C., Chen Y., Cline G.W., Zhang D., Zong H., Wang Y., Bergeron R., Kim J.K., Cushman S.W., Cooney G.J., et al. Mechanism by which fatty acids inhibit insulin activation of insulin receptor substrate-1 (IRS-1)-associated phosphatidylinositol 3-kinase activity in muscle. J. Biol. Chem. 277 (2002) 50230-50236